Avecho Biotechnology (ASX:AVE) Pretax Margin %: -254.90% (As of Dec. 2025)

What is Avecho Biotechnology Pretax Margin %?

Avecho Biotechnology ASX:AVE Pretax Margin % is -254.90% as of Dec. 2025. The stock has 2 warning signs investors should review. Among 938 Biotechnology companies, Avecho Biotechnology ranks worse than 66.63% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Avecho Biotechnology's Pre-Tax Income for the six months ended in Dec. 2025 was A$-1.74 Mil. Avecho Biotechnology's Revenue for the six months ended in Dec. 2025 was A$0.68 Mil. Therefore, Avecho Biotechnology's pretax margin for the quarter that ended in Dec. 2025 was -254.90%.

The historical rank and industry rank for Avecho Biotechnology's Pretax Margin % or its related term are showing as below:

ASX:AVE' s Pretax Margin % Range Over the Past 10 Years
Min: -1085.96 Med: -392.51 Max: 20.06
Current: -354.78

ASX:AVE's Pretax Margin % is ranked worse than
66.63% of 938 companies
in the Biotechnology industry
Industry Median: -89.895 vs ASX:AVE: -354.78

Avecho Biotechnology (ASX:AVE) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Avecho Biotechnology Pretax Margin % Related Terms

Avecho Biotechnology Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Avecho Biotechnology's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avecho Biotechnology Pretax Margin % Chart

Avecho Biotechnology Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Pretax Margin %

Get a 7-Day Free Trial

-430.23

-194.20

-725.11

-275.55

-354.78

Avecho Biotechnology Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Pretax Margin %	Get a 7-Day Free Trial															-4,848.15	-461.78	-143.27	-476.16	-254.90

ASX:AVE vs VRTX, REGN, ALNY: Pretax Margin % Comparison

For the Biotechnology subindustry, Avecho Biotechnology's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avecho Biotechnology Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avecho Biotechnology's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Avecho Biotechnology's Pretax Margin % falls into.

Save Embed

Avecho Biotechnology Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Avecho Biotechnology's Pretax Margin for the fiscal year that ended in Dec. 2025 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-4.417	/	1.245
	=	-354.78 %

Avecho Biotechnology's Pretax Margin for the quarter that ended in Dec. 2025 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Dec. 2025 )	/	Revenue (Q: Dec. 2025 )
	=	-1.741	/	0.683
	=	-254.90 %

Frequently Asked Questions Learn more about Pretax Margin % →

What does a Pretax Margin % of -254.90% mean?

Avecho Biotechnology (ASX:AVE) has a Pretax Margin % of -254.90% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Avecho Biotechnology and its competitors. According to the industry distribution chart, Avecho Biotechnology ranks #625 out of 938 companies in the Biotechnology industry, placing it in the top 66.6%.

Is Avecho Biotechnology's Pretax Margin % too high?

Avecho Biotechnology's current Pretax Margin % is -254.90%. Based on the distribution chart, Avecho Biotechnology ranks #625 out of 938 companies in the Biotechnology industry, which is below the industry midpoint.

How does Avecho Biotechnology's Pretax Margin % compare to VRTX and REGN?

According to the Biotechnology industry distribution chart, Avecho Biotechnology ranks #625 out of 938 companies for Pretax Margin %. This places Avecho Biotechnology in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Pretax Margin % for a Biotechnology company?

A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Pretax Margin % mean?

A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Avecho Biotechnology and its competitors. Avecho Biotechnology's current Pretax Margin % is -254.90%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Avecho Biotechnology stock overvalued right now?

Avecho Biotechnology (ASX:AVE) has a current Pretax Margin % of -254.90%. The current Pretax Margin % is -254.90%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Pretax Margin % calculated?

Pretax Margin % is calculated from a company's financial statements. For Avecho Biotechnology (ASX:AVE), the current Pretax Margin % is -254.90% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avecho Biotechnology Business Description

Industry Healthcare Biotechnology

Comparable Companies ASX:ATX ASX:IMM ASX:PTX ASX:ALA ASX:ENP ASX:BOT ASX:PAR ASX:NXN ASX:RAD ASX:NUZ VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges OEZ:Germany

Address Unit A8, 2A Westall Road, Clayton, Melbourne, VIC, AUS, 3168

Website https://www.avecho.com.au

Avecho Biotechnology Ltd is a research-based biotechnology company engaged in the development, production, sales, and licensing of products incorporating its patented platform technology Tocopheryl Phosphate Mixture (TPM), for the pharmaceutical, skincare, and animal health and nutrition industries. Its segments include Production, Human Health, and other segments. The Production segment, which is the key revenue driver, manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers the delivery of drugs through gels, injectables, and patches, including the conduct of research and development activities. It focuses on the development of patches, including TPM/Oxymorphone and TPM/Oxycodone.